Thyroid cancers express CD-40 and CD-40 ligand: Cancers that express CD-40 ligand may have a greater risk of recurrence in young patients

Amy Costello, Christine Rey-Hipolito, Aneeta Patel, Kevin Oakley, Vasyl Vasco, Chris Calabria, R. Michael Tuttle, Gary L. Francis

Research output: Contribution to journalArticlepeer-review

7 Scopus citations

Fingerprint Dive into the research topics of 'Thyroid cancers express CD-40 and CD-40 ligand: Cancers that express CD-40 ligand may have a greater risk of recurrence in young patients'. Together they form a unique fingerprint.

Medicine & Life Sciences